Abstract:Background Lupus is a complex chronic systemic autoimmune disease. Dysregulation of interferon-alpha (IFN-) response has been associated with the pathogenesis of lupus. Genetic variants constitute the risk factors for the development of lupus, with many SNPs identified to pose the risk of lupus. However, the functions of the host genes of these SNPs are not fully understood. Recent studies show SNP rs4850410 is associated with serum IFN- levels in European-Americans and Afican-Americans. Rs4850410 is located in the intronic region of ANKRD44 which encodes a subunit of ankyin repeat domain of protein phosphatase 6 (PP6) that is involved in an array of important cellular processes, such as the regulation of metabolism, transcription, and apoptosis. However, if ANKRD44 regulates IFN responses is unknown. In this study, we aimed to investigate the function of ANKRD44 in controlling IFN response, and its association with the pathogenesis of lupus. Methods PBMCs were collected from 46 SLE patients and 48 healthy controls. The mRNA expression of ANKRD44 and IFN-inducible genes was detected by real time PCR. The mRNA expression of ANKRD44 was measured at different time points in Raw264.7 cells during IFN stimulation. ANKRD44 was knocked down by using siRNA. The activation of IFN signaling pathway were examined by western blotting at different time points in Raw264.7 cells. Results The mRNA expression levels of ANKRD44 were decreased in PBMCs from SLE patients compared to healthy controls. The expression of ANKRD44 was downregulated when stimulating by poly(I:C) or IFN in Raw264.7 cells. Knockdown of ANKRD44 up-regulated the expression of IFN-inducible genes (such as IFIT3 and CCL2). Consistently, knockdown of ANKRD44 promoted the phosphorylation of STAT1, STAT2, JAK1 and TYK2 stimulated by IFN in Raw264.7 cells. Conclusions Our study indicates that ANKRD44 functions as a negative regulator in type I IFN signaling pathway. Decreased expression of ANKRD44 constitutes one of the mechanisms for dysregulated IFN response in SLE, which may play important roles in the pathogenesis of Lupus. Funding Source(s): This work was supported by the National Basic Research Program of China (973 program) grant 2014CB541902 and the National Natural Science Foundation of China (No.81401331).

Sequential Activation of Protein Kinase C Δ and JNK is Required for Interferon-Α-induced Expression of IFIT4

Ifr-9/Stat2 Functional Interaction Drives Retinoic Acid-Induced Gene G Expression Independently Of Stat1

Interferon-induced Protein IFIT4 is Associated with Systemic Lupus Erythematosus and Promotes Differentiation of Monocytes into Dendritic Cell-Like Cells

Protein Interaction for an Interferon-Inducible Systemic Lupus Associated Gene, IFIT1

Interferon-α-induced Expression of Phospholipid Scramblase 1 Through STAT1 Requires the Sequential Activation of Protein Kinase Cδ and JNK

Identification of Cyclin-Dependent Kinase 1 As a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.

A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1

Expressions of interferon-inducible genes in patients with systemic lupus erythematosus and their assoc-iation with disease activity

The expression of IKB kinase in the peripheral blood and its correlation with the production of interferon-α in systemic lupus erythematosus patients

AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus

Synergistic Activation of Interleukin-12 P35 Gene Transcription by Interferon Regulatory Factor-1 and Interferon Consensus Sequence-Binding Protein

IFIT3 mediates TBK1 phosphorylation to promote activation of pDCs and exacerbate systemic sclerosis in mice

Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation.

[Using GST-tag to Capture Protein Interaction of an Interferon-Inducible Systemic Lupus Associated Gene, IFIT1].

TIGIT reverses IFN-α-promoted Th1-like Tregs via in-sequence effects dependent on STAT4

Involvement of type Ⅰ interferon in modulating activation and TLRs expression on T cells in systemic lupus erythematosus

Effect of IFN-α on KC and LIX Expression: Role of STAT1 and Its Effect on Neutrophil Recruitment to the Spleen after Lipopolysaccharide Stimulation

82 Decreased expression of ANKRD44 associates with the overactivation of type I IFN signaling pathway in SLE

Association of Abnormal Elevations in IFIT3 with Overactive Cyclic GMP‐AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes

Effect of IFIT3 Gene in the Pathogenesis of Systemic Lupus Erythematosus and Construction of Its Eukaryotic Expression Plasmid